These include upstream signalling and transcription MK-2206 concentration factor interactions. Several members of the retinoic acid receptor (RAR) orphan receptor (ROR) family have been described as transcription factors expressed specifically in Th17 cells. These include RORα and RORγt [90–92], which are encoded by the genes RORA and RORC. RORγt is induced by TGF-β and IL-6 in naive Thp and leads to transcription of

IL-17 [90]. As expected, overexpression of RORγt promotes Th17 differentiation. However, while RORγt-deficient mice have reduced numbers of Th17 cells, the population is not depleted [90]. This is because RORα is also expressed highly in TGF-β/IL-6-induced Th17 cells [91]. This related transcription factor synergizes with RORγt to induce Th17 differentiation, and elimination of both RORα and RORγt (double-deficient animals) at the same time is required to RG7204 ic50 deplete Th17 differentiation effectively and protect against Th17-driven autoimmune diseases [91]. The Scurfy mouse (sf), an X-linked mutant strain, described in 1949 (loc. cit. [93], exhibits a series of autoimmune features including skin scaliness, diarrhoea

and death (between 2 and 4 weeks after birth) in association with CD4+ T cell hyperproliferation, multi-organ CD4+ cell infiltration [94] and over-production of several inflammatory cytokines [95]. This fatal autoimmune lymphoproliferative syndrome maps to a gene locus on the X chromosome called foxp3, which has been described as a member of the forkhead/winged-helix family of transcription factors [96]. The foxp3 gene is highly conserved between species and a mutation in the human gene, FOXP3, has been identified as the causative factor responsible for the human equivalent of Scurfy, the immunodysregulation, polyendocrinopathy

and enteropathy, X-linked syndrome (IPEX), also known as X-linked autoimmunity and allergic dysregulation syndrome (XLAAD) [19,97,98]. Both the mouse and human disease lack discrete circulating Tregs, which suggests that foxp3 and FOXP3 are essential for normal Treg development in the two species, respectively. This position is strengthened by the failure of foxp3 knock-out mice to develop circulating Tregs; these animals develop a Scurfy-like cAMP inhibitor syndrome from which they can be rescued by the adoptive transfer of Tregs from a foxp3 replete animal [99]. Furthermore, ectopic or over-expression of foxp3 in CD4+CD25- mouse cells results in development of a Treg phenotype [97,99,100]. In mice, FoxP3 expression is a good phenotypic marker of Tregs[101,102]; in humans, however, FoxP3 does not allow the unambiguous identification of Tregs[103], as FoxP3 is induced during TCR stimulation in conventional CD4+ T cells [104–106] (in much the same manner as CD25) and there is some debate as to whether the induced CD4+CD25+FoxP3+ population is suppressive or anergic [104,105].